Home | Yusuf Hamied |
|
Financial Times--"It's about monopoly and delay," says -Yusuf Hamied-, head of Cipla, who initially thought that once GSK had lost the patents in its home market in 2004 it ... Tue, 25 May 2010 00:53:22 GMT+00:00 |